Cutaneous manifestations in treated Whipple's disease

Int J Dermatol. 2017 Apr;56(4):e82-e84. doi: 10.1111/ijd.13479. Epub 2017 Feb 8.

Authors

Sebastiaan van der Bent¹, Michèle van Vugt², Avital Amir³, Allard van der Wal³, Jan Mekkes¹

Affiliations

¹ Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
² Division of Internal Medicine, Department of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 28181229
DOI: 10.1111/ijd.13479

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
Ceftriaxone / therapeutic use
Erythema / microbiology*
Erythema / pathology
Humans
Immune Reconstitution Inflammatory Syndrome / microbiology*
Immune Reconstitution Inflammatory Syndrome / pathology
Male
Middle Aged
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
Whipple Disease / complications*
Whipple Disease / drug therapy*

Substances

Anti-Bacterial Agents
Ceftriaxone
Trimethoprim, Sulfamethoxazole Drug Combination